Thursday, 16 November 2017

Latest natalizumab PML risk update

The latest PML risk figures from Biogen. If you are on natalizumab and are JCV seropositive this post is for you.








ProfG    

3 comments:

  1. Surely it is time to remove natalizumab from the market? With all the new and safer DMTs it is time for change.

    ReplyDelete
    Replies
    1. I am JCV-ve and doing very well thank you. I don't want any new DMT without a long-term safety record.

      Delete
  2. Please do you have any comments on the data about 27% free of disease activity at 24 months? I thought it is more as natalizumab is one of the most potent medicines ...

    ReplyDelete

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.